Home> Products> sustained release sr tablet

{ "products": [ { "_id": "6668450404b14f234440a3d6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "pregabalin and methylcobalamin tablets", "description": "PREGABRIAL M FORTE \nPregabalin (SR) & Methylcobalamin\nIntroduction\nPREGABRIAL M FORTE is a combination medication that includes Pregabalin (Sustained Release) and Methylcobalamin. This powerful formulation is designed to provide prolonged relief from neuropathic pain while supporting nerve health. The sustained release of Pregabalin ensures consistent therapeutic levels throughout the day, while Methylcobalamin promotes nerve repair and overall vitality. This combination is particularly effective for individuals suffering from chronic pain conditions requiring long-term management.\n\nKey Ingredients and Their Benefits\nPregabalin (Sustained Release)\nNeuropathic Pain Relief: Pregabalin is highly effective in reducing neuropathic pain caused by nerve damage due to conditions like diabetes, shingles, or spinal cord injury.\nAnticonvulsant: It helps control partial seizures by reducing abnormal electrical activity in the brain, making it an important medication for epilepsy management.\nAnxiety Reduction: Pregabalin also has anxiolytic properties, beneficial for patients with generalized anxiety disorder (GAD).\nSustained Release: The sustained release formulation allows for a gradual release of the medication, providing prolonged pain relief and reducing the frequency of dosing.\nMethylcobalamin\nNerve Health: Methylcobalamin, a form of Vitamin B12, is essential for maintaining healthy nerve cells and repairing nerve damage.\nEnergy Production: It plays a crucial role in energy production and the synthesis of DNA, helping to reduce fatigue and improve overall vitality.\nCognitive Function: Methylcobalamin supports cognitive health by aiding in the production of neurotransmitters that are essential for brain function.\nBenefits of PREGABRIAL M FORTE\nProlonged Pain Relief: The sustained release of Pregabalin ensures consistent and prolonged relief from neuropathic pain, enhancing daily functioning and quality of life.\nEnhanced Nerve Health: Methylcobalamin supports nerve regeneration and repair, contributing to long-term nerve health and function.\nImproved Quality of Life: By alleviating pain and supporting nerve health, PREGABRIAL M FORTE helps improve overall quality of life for individuals with chronic pain conditions.\nAnxiety and Seizure Control: Pregabalin's anxiolytic and anticonvulsant properties provide additional benefits for patients with anxiety disorders and partial seizures.\nReduced Dosing Frequency: The sustained release formulation reduces the need for frequent dosing, improving patient compliance and convenience.\nDosage and Administration\nDosage\nRecommended Dosage: The typical dosage of PREGABRIAL M FORTE is one tablet taken once or twice daily, depending on the condition being treated and the patient's response to treatment. The exact dosage should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It is best taken with food to minimize gastrointestinal discomfort.\nConsistency: For optimal results, take PREGABRIAL M FORTE at the same times each day to maintain an even level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/pregabrial-m-forte-134209", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "GAD", "DNA", "food", "life", "need", "EMAIL", "water", "fatigue", "patients", "response", "Oral Use", "diabetes", "shingles", "treatment", "synthesis", "Pregabalin", "one tablet", "full glass", "same times", "even level", "individuals", "convenience", "Vitamin B12", "Consistency", "bloodstream", "information", "nerve damage", "Introduction", "crucial role", "exact dosage", "sterispharma", "nerve repair", "sterisonline", "CALL/WHATSAPP", "brain function", "typical dosage", "Key Ingredients", "Seizure Control", "optimal results", "gradual release", "overall quality", "Methylcobalamin", "frequent dosing", "Improved Quality", "cognitive health", "overall vitality", "partial seizures", "prolonged relief", "Energy Production", "Anxiety Reduction", "anxiety disorders", "neurotransmitters", "daily functioning", "spinal cord injury", "nerve regeneration", "PREGABRIAL M FORTE", "patient compliance", "Recommended Dosage", "Cognitive Function", "additional benefits", "healthcare provider", "healthy nerve cells", "epilepsy management", "long-term management", "powerful formulation", "Administration Dosage", "anxiolytic properties", "Enhanced Nerve Health", "prolonged pain relief", "combination medication", "long-term nerve health", "chronic pain conditions", "Neuropathic Pain Relief", "Reduced Dosing Frequency", "anticonvulsant properties", "gastrointestinal discomfort", "generalized anxiety disorder", "abnormal electrical activity", "sustained release formulation", "consistent therapeutic levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1744, "imageuri": "https://productimages.withfloats.com/actual/667d29fa5e58b0758f704d13.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d29fa5e58b0758f704d13.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-11T12:37:24.05Z", "updatedon": "2025-12-17T08:08:03.251Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pregabalin-and-methylcobalamin-tablets/1744", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PREGABRIAL M FORTE ", "category": "ORTHOLOGYRANGE", "tags": [ "pregabrial m forte ingredients", "pregabrial m forte manufacturer", "pregabrial m forte ingredients list", "pregabrial m forte brands in india", "pregabrial m forte price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666d9ada4e54e1dc4565d73", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NITROTIME SR 100 ", "description": "NITROTIME SR 100 \nNitrofurontoin(100mg) SR\nNitrofurantoin SR 100 is a sustained-release formulation of nitrofurantoin, an antibiotic used to treat urinary tract infections (UTIs). It belongs to the class of nitrofuran antibiotics and works by interfering with the growth of bacteria, particularly those causing UTIs.\n\nUses:\n\nUrinary Tract Infections (UTIs): Nitrofurantoin SR 100 is effective against UTIs caused by susceptible strains of bacteria. It is commonly prescribed for uncomplicated lower UTIs.\nHow It Works:\nNitrofurantoin SR 100 works by inhibiting bacterial cell wall synthesis, DNA, RNA, and protein synthesis in susceptible bacteria, leading to their death. Its sustained-release formulation allows for extended drug action, reducing the frequency of dosing.\n\nDosage and Administration:\n\nThe typical dosage for adults is one Nitrofurantoin SR 100 tablet (100mg) taken orally twice daily with food or milk to reduce stomach upset.\nFollow your healthcare provider's instructions regarding dosage and duration of treatment.\nSwallow the tablet whole; do not crush or chew it.\nComplete the full course of medication as prescribed, even if symptoms improve before the course is finished.\nPrecautions:\n\nInform your healthcare provider about any allergies or medical conditions before taking Nitrofurantoin SR 100.\nAvoid alcohol consumption during treatment with Nitrofurantoin as it may increase the risk of side effects.\nUse caution if you have kidney problems, as dose adjustment may be necessary.\nMonitor for signs of allergic reactions or severe side effects and seek medical attention if they occur.\nSide Effects:\nCommon side effects of Nitrofurantoin SR 100 may include:\n\nNausea\nVomiting\nDiarrhea\nHeadache\nDizziness\nSkin rash\nStorage:\nStore Nitrofurantoin SR 100 at room temperature away from moisture, heat, and light. Keep out of reach of children.\n\nConclusion:\nNitrofurantoin SR 100 is a valuable antibiotic for treating UTIs, providing effective relief with its sustained-release formulation and manageable side effect profile when used as directed under medical supervision. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/nitrotime-sr-100-133497", "price": 165.0, "discountamount": 50.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RNA", "DNA", "Uses", "milk", "food", "heat", "risk", "Call", "reach", "light", "death", "Store", "ORDER", "signs", "Email", "class", "100mg", "adults", "dosing", "growth", "Nausea", "WhatsApp", "duration", "children", "symptoms", "Vomiting", "Diarrhea", "Headache", "moisture", "treatment", "allergies", "Dizziness", "frequency", "Conclusion", "medication", "full course", "Precautions", "information", "instructions", "sterispharma", "sterisonline", "stomach upset", "typical dosage", "Administration", "dose adjustment", "kidney problems", "effective relief", "room temperature", "Skin rash Storage", "medical attention", "protein synthesis", "allergic reactions", "medical conditions", "severe side effects", "Common side effects", "susceptible strains", "alcohol consumption", "medical supervision", "valuable antibiotic", "healthcare provider", "susceptible bacteria", "extended drug action", "nitrofuran antibiotics", "uncomplicated lower UTIs", "urinary tract infections", "sustained-release formulation", "bacterial cell wall synthesis", "manageable side effect profile", "NITROTIME SR 100 Nitrofurontoin", "one Nitrofurantoin SR 100 tablet" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1677, "imageuri": "https://productimages.withfloats.com/actual/667d3fc1000f6c164f096711.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3fc1000f6c164f096711.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:47:09.659Z", "updatedon": "2024-06-27T10:32:27.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nitrotime-sr-100-/1677", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NITROTIME SR 100 ", "category": "UROLOGYRANGE", "tags": [ "NITROTIME SR 100 mg", "Nitrofurontoin 100mg SR", "Nitrofurontoin(100mg) SR", "Nitrofur SR 100 uses", "Nitrofur SR 100 side effects", "Nitrofur SR 100 mg Tablet Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66619067161afa2274ff4f3b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET SR 850 ", "description": "SEIZMET SR 850 \nMetformin SR (850mg) \nIntroduction to SEIZMET SR 850\nSEIZMET SR 850 contains Metformin Hydrochloride 850mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Metformin belongs to a class of drugs known as biguanides, which help control blood sugar levels by improving the body's response to insulin. The sustained-release formulation ensures a prolonged effect throughout the day, providing steady glycemic control.\n\nWhat is Metformin?\nOverview of Metformin\nMetformin is an oral diabetes medication that helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It also enhances glucose uptake and utilization in peripheral tissues, making it an effective treatment for type 2 diabetes.\n\nMechanism of Action\nInsulin Sensitization: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, allowing cells to absorb glucose more effectively.\nGlucose Uptake: By enhancing insulin sensitivity, Metformin helps muscles and adipose tissues take up glucose from the bloodstream, lowering blood sugar levels.\nReduced Glucose Production: Metformin decreases the amount of glucose produced by the liver, contributing to overall glycemic control.\nBenefits of SEIZMET SR 850\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: SEIZMET SR 850 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting both insulin sensitivity and hepatic glucose production, Metformin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET SR 850 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET SR 850 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Neutral or Loss: Unlike some other diabetes medications, Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has been shown to have beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET SR 850\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET SR 850 is one tablet taken once daily with the evening meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET SR 850 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-sr-850-133444", "price": 38.7, "discountamount": 11.61, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "cells", "class", "Order", "EMAIL", "drugs", "water", "meals", "liver", "amount", "Action", "stroke", "option", "Support", "muscles", "readings", "Overview", "biguanides", "full glass", "one tablet", "neuropathy", "overweight", "Guidelines", "bloodstream", "utilization", "information", "retinopathy", "Optimal Use", "Adjustments", "Metformin SR", "Introduction", "sterispharma", "Reduced Risk", "best results", "evening meal", "sterisonline", "heart disease", "CALL/WHATSAPP", "SEIZMET SR 850", "glucose uptake", "Consistent Use", "Administration", "Weight Neutral", "obese patients", "typical dosage", "treatment plan", "unique mechanism", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "Recommended Dosage", "modest weight loss", "peripheral tissues", "beneficial effects", "blood sugar control", "individual response", "Diabetes Management", "effective treatment", "healthcare provider", "insulin sensitivity", "cardiovascular health", "Insulin Sensitization", "cardiovascular disease", "Metformin Hydrochloride", "steady glycemic control", "Cardiovascular Benefits", "long-term complications", "lifestyle modifications", "type 2 diabetes mellitus", "overall glycemic control", "oral diabetes medication", "stable blood sugar levels", "Reduced Glucose Production", "Additional Health Benefits", "hepatic glucose production", "other diabetes medications", "gastrointestinal discomfort", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1451, "imageuri": "https://productimages.withfloats.com/actual/66619068c06ee12d88cfeb92.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66619068c06ee12d88cfeb92.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:33:11.434Z", "updatedon": "2024-06-29T07:30:36.594Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-sr-850-/1451", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET SR 850 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET SR 850", "Metformin SR (850mg)", "Glycomet 850 SR in pregnancy", "Glycomet SR 850 composition", "Glycomet SR 850 side effects", "Metformin 850 mg price", "Glycomet 850 SR uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666186bbe69b8516f884c516", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET SR 1000 ", "description": "SEIZMET SR 1000 \nMetformin Hydrochloride Sustained Release IP 1000 mg\nIntroduction to SEIZMET SR 1000\nSEIZMET SR 1000 contains Metformin Hydrochloride 1000mg in a sustained-release formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Metformin belongs to a class of drugs known as biguanides, which help control blood sugar levels by improving the body's response to insulin. The sustained-release formulation ensures a prolonged effect throughout the day, providing steady glycemic control.\n\nWhat is Metformin?\nOverview of Metformin\nMetformin is an oral diabetes medication that helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It also enhances glucose uptake and utilization in peripheral tissues, making it an effective treatment for type 2 diabetes.\n\nMechanism of Action\nInsulin Sensitization: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, allowing cells to absorb glucose more effectively.\nGlucose Uptake: By enhancing insulin sensitivity, Metformin helps muscles and adipose tissues take up glucose from the bloodstream, lowering blood sugar levels.\nReduced Glucose Production: Metformin decreases the amount of glucose produced by the liver, contributing to overall glycemic control.\nBenefits of SEIZMET SR 1000\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: SEIZMET SR 1000 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting both insulin sensitivity and hepatic glucose production, Metformin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET SR 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET SR 1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Neutral or Loss: Unlike some other diabetes medications, Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has been shown to have beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET SR 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET SR 1000 is one tablet taken once daily with the evening meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET SR 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-sr-1000-134083", "price": 45.36, "discountamount": 13.61, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "body", "Diet", "cells", "class", "EMAIL", "Order", "liver", "drugs", "water", "meals", "amount", "stroke", "Action", "option", "Support", "muscles", "Overview", "readings", "full glass", "SEIZMET SR", "biguanides", "one tablet", "Guidelines", "overweight", "neuropathy", "Optimal Use", "Adjustments", "retinopathy", "information", "bloodstream", "utilization", "evening meal", "best results", "Introduction", "sterispharma", "Reduced Risk", "sterisonline", "heart disease", "CALL/WHATSAPP", "typical dosage", "treatment plan", "obese patients", "Consistent Use", "Weight Neutral", "Administration", "glucose uptake", "unique mechanism", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "Recommended Dosage", "peripheral tissues", "modest weight loss", "beneficial effects", "blood sugar control", "effective treatment", "individual response", "Diabetes Management", "healthcare provider", "insulin sensitivity", "cardiovascular health", "Insulin Sensitization", "cardiovascular disease", "lifestyle modifications", "Cardiovascular Benefits", "long-term complications", "steady glycemic control", "overall glycemic control", "type 2 diabetes mellitus", "oral diabetes medication", "stable blood sugar levels", "Reduced Glucose Production", "hepatic glucose production", "other diabetes medications", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management", "Metformin Hydrochloride Sustained Release IP" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1444, "imageuri": "https://productimages.withfloats.com/actual/666186bf6030c166b1a95a6f.png", "tileimageuri": "https://productimages.withfloats.com/tile/666186bf6030c166b1a95a6f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:51:55.688Z", "updatedon": "2024-06-29T09:06:02.504Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-sr-1000-/1444", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET SR 1000 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET SR 1000", "Metformin Hydrochloride Sustained Release IP 1000 ", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride used for", "Metformin hydrochloride 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665eff188da3a81d5c69e749", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/1000 SR ", "description": "GLIDAPA 3D 10/100/1000 SR \nDapaflozin 10, Sitagliptin 100 mg & Metformin SR 1000 mg\nIntroduction\nGLIDAPA 3D 10/100/1000 SR is a comprehensive oral medication tailored for the treatment of Type 2 diabetes. This potent combination incorporates Dapagliflozin (10 mg), Sitagliptin (100 mg), and a higher dose of Metformin (1000 mg, sustained release), designed to effectively manage high blood sugar levels throughout the day.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin facilitates the removal of excess glucose from the body via the urine, helping to reduce blood glucose levels and also supporting weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin increases the levels of incretin hormones, which enhances the pancreatic response to high blood sugar after meals by increasing insulin production and decreasing glucagon secretion.\nMetformin SR (1000 mg): The higher dose of Metformin in this formulation works to decrease hepatic glucose production, improve insulin sensitivity, and reduce glucose absorption in the intestines. The sustained-release form minimizes gastrointestinal side effects and provides more stable blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/1000 SR offers a potent therapeutic strategy by combining three drugs, each targeting a different aspect of diabetes management. This not only maximizes glucose control but also simplifies the treatment regimen, potentially enhancing patient compliance and reducing the risk of long-term complications.\n\nDosage and Administration\n\nDosage: The dosage should be tailored to the individual’s current health status, effectiveness of the treatment, and tolerability. Regular monitoring of blood glucose and adjustment of the dose may be necessary.\nAdministration: It is recommended to take the medication once daily in the morning, with or without food. The tablet should be swallowed whole to ensure proper release of Metformin over time.\nSide Effects\nCommon side effects may include urinary tract infections (due to Dapagliflozin), potential gastrointestinal disturbances such as nausea or diarrhea (common with Metformin), and a sore throat or nasopharyngitis associated with Sitagliptin. These side effects are generally mild and manageable.\n\nConclusion\nGLIDAPA 3D 10/100/1000 SR is a highly effective option for managing Type 2 diabetes, offering a strategic blend of three medications to control blood sugar levels, improve metabolic health, and reduce the risk of diabetes-related complications. This enhanced formulation is suitable for patients requiring a robust approach to diabetes management, emphasizing the importance of ongoing collaboration with healthcare providers to tailor and optimize treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-1000-sr-134216\n\n\n\n\n\n", "price": 595.0, "discountamount": 178.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "time", "food", "body", "risk", "meals", "Order", "EMAIL", "urine", "nausea", "tablet", "Action", "morning", "1000 mg", "removal", "patients", "Benefits", "diarrhea", "Mechanism", "Conclusion", "Dapaflozin", "intestines", "adjustment", "importance", "individual", "weight loss", "Sitagliptin", "higher dose", "three drugs", "information", "sore throat", "tolerability", "Introduction", "sterisonline", "sterispharma", "Metformin SR", "Dapagliflozin", "CALL/WHATSAPP", "effectiveness", "proper release", "excess glucose", "SGLT2 inhibitor", "Type 2 diabetes", "robust approach", "DPP-4 inhibitor", "strategic blend", "nasopharyngitis", "glucose control", "metabolic health", "different aspect", "effective option", "sustained release", "treatment regimen", "incretin hormones", "three medications", "glucagon secretion", "Regular monitoring", "patient compliance", "glucose absorption", "insulin production", "potent combination", "pancreatic response", "diabetes management", "insulin sensitivity", "Common side effects", "enhanced formulation", "healthcare providers", "blood glucose levels", "ongoing collaboration", "cardiovascular health", "Administration Dosage", "current health status", "sustained-release form", "high blood sugar levels", "long-term complications", "urinary tract infections", "GLIDAPA 3D 10/100/1000 SR", "stable blood sugar control", "hepatic glucose production", "potent therapeutic strategy", "gastrointestinal side effects", "comprehensive oral medication", "diabetes-related complications", "potential gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1303, "imageuri": "https://productimages.withfloats.com/actual/665eff1a8e77bb2c7151ebf4.png", "tileimageuri": "https://productimages.withfloats.com/tile/665eff1a8e77bb2c7151ebf4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:48:40.052Z", "updatedon": "2024-06-04T11:48:40.052Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-1000-sr-/1303", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/1000 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665efdbd66170d1ff8cb13bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/500 SR ", "description": "GLIDAPA 3D 10/100/500 SR \nDapaflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg\nIntroduction\nGLIDAPA 3D 10/100/500 SR is a sophisticated, multi-mechanism oral medication designed for the management of Type 2 diabetes. It combines Dapagliflozin (10 mg), Sitagliptin (100 mg), and Metformin (500 mg, sustained release), offering a robust, integrated approach to controlling high blood glucose levels.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin promotes the excretion of glucose through urine by blocking its reabsorption in the kidneys. This helps to lower blood sugar levels and also has benefits for weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin works by enhancing the body's own ability to lower blood glucose levels in response to meals. It does this by increasing the levels of incretin hormones, which affect the pancreas to produce more insulin and less glucagon.\nMetformin SR (500 mg): Metformin works primarily by reducing glucose production in the liver, improving insulin sensitivity, and lowering glucose absorption in the gut. The sustained-release (SR) formulation ensures a steady release over time, minimizing gastrointestinal side effects and maintaining more consistent blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/500 SR provides a comprehensive treatment solution by addressing several key pathways in glucose metabolism, thereby reducing the risk of both hyperglycemia and associated complications. The combination of these three active substances in a single formulation enhances convenience and potentially improves adherence to treatment protocols.\n\nDosage and Administration\n\nDosage: The recommended starting dose depends on the patient’s current treatment regimen and their specific health profile. Adjustments should be made based on effectiveness and tolerability, under the guidance of a healthcare professional.\nAdministration: This medication should be taken once daily in the morning, with or without food. The tablet should be swallowed whole to maintain the sustained release of Metformin.\nSide Effects\nPossible side effects of GLIDAPA 3D 10/100/500 SR include urinary tract and genital infections (due to Dapagliflozin), nausea or a sore throat (from Sitagliptin), and digestive issues such as diarrhea or abdominal pain (common with Metformin). Most side effects are manageable and tend to decrease over time.\n\nConclusion\nGLIDAPA 3D 10/100/500 SR is a versatile and effective option for those managing Type 2 diabetes, offering triple-action treatment in one convenient medication. It targets various aspects of diabetes management, improves glycemic control, and enhances overall quality of life. Patients are advised to maintain regular follow-ups with their healthcare provider to optimize treatment outcomes and manage any side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-500-sr-134215", "price": 575.0, "discountamount": 172.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "gut", "time", "life", "risk", "food", "body", "urine", "liver", "EMAIL", "Order", "meals", "500 mg", "nausea", "tablet", "patient", "ability", "kidneys", "morning", "response", "diarrhea", "pancreas", "guidance", "benefits", "adherence", "versatile", "excretion", "Conclusion", "sore throat", "Sitagliptin", "weight loss", "Adjustments", "combination", "information", "convenience", "Introduction", "sterispharma", "Metformin SR", "reabsorption", "sterisonline", "urinary tract", "CALL/WHATSAPP", "hyperglycemia", "Dapagliflozin", "less glucagon", "effectiveness", "starting dose", "abdominal pain", "steady release", "overall quality", "SGLT2 inhibitor", "various aspects", "Type 2 diabetes", "DPP-4 inhibitor", "Dapaflozin 10 mg", "effective option", "digestive issues", "glycemic control", "Most side effects", "sustained release", "incretin hormones", "regular follow-ups", "genital infections", "blood sugar levels", "glucose metabolism", "glucose absorption", "glucose production", "treatment outcomes", "single formulation", "diabetes management", "insulin sensitivity", "healthcare provider", "treatment protocols", "several key pathways", "Administration Dosage", "Possible side effects", "cardiovascular health", "triple-action treatment", "specific health profile", "three active substances", "healthcare professional", "associated complications", "GLIDAPA 3D 10/100/500 SR", "current treatment regimen", "one convenient medication", "high blood glucose levels", "robust, integrated approach", "gastrointestinal side effects", "consistent blood sugar control", "comprehensive treatment solution", "sustained-release (SR) formulation", "sophisticated, multi-mechanism oral medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1300, "imageuri": "https://productimages.withfloats.com/actual/665efdc0e874b19df8b5f4ce.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efdc0e874b19df8b5f4ce.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:42:53.803Z", "updatedon": "2024-06-04T11:42:53.803Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-500-sr-/1300", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/500 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ef7cfea22b014e8aefff9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MR 30 ", "description": "GLICLAGLAZE MR 30 \ngliclazide sr (30 mg)\nIntroduction\nGLICLAGLAZE MR 30 is specifically formulated for individuals managing Type 2 diabetes. This medication utilizes a sustained release (SR) form of Gliclazide at a 30 mg dosage, focusing on providing a steady, controlled release of the drug to maintain optimal blood sugar levels throughout the day.\n\nHow It Works\n\nGliclazide SR (30 mg): Gliclazide is a sulfonylurea class drug that increases insulin secretion from the pancreas. Unlike standard formulations, the SR version releases the medication gradually, which helps to stabilize blood sugar levels and reduces the risk of severe fluctuations that can lead to hypoglycemia. This mechanism not only enhances the body’s natural insulin use but also supports overall vascular health, decreasing the risk of complications associated with diabetes, such as cardiovascular disease.\nBenefits\nGLICLAGLAZE MR 30 is an excellent choice for patients who require a mild enhancement in their insulin secretion with a lower risk of hypoglycemia. The SR formulation provides a more predictable pharmacokinetic profile, which is crucial for maintaining a stable glycemic control. This can significantly improve the quality of life for patients by reducing common side effects associated with blood sugar spikes and drops.\n\nDosage and Administration\n\nDosage: The dose of GLICLAGLAZE MR 30 should be adjusted based on the patient’s blood glucose response and previous treatment history. Regular monitoring of blood glucose and glycated hemoglobin (HbA1c) levels is recommended to ensure that the dosage is effective.\nAdministration: This medication should be taken with breakfast or the first main meal of the day. The tablet should be swallowed whole to maintain the integrity of the sustained release mechanism.\nSide Effects\nPossible side effects of GLICLAGLAZE MR 30 include gastrointestinal issues such as nausea and upset stomach. Due to its sulfonylurea component, there is a risk of hypoglycemia, although it is generally lower compared to other sulfonylureas due to the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MR 30 is a practical and effective solution for managing Type 2 diabetes, especially suited for patients seeking a gentle modification in their diabetes treatment plan with sustained drug release. It simplifies diabetes management, potentially enhancing adherence and minimizing the risk of dosage-related complications. As with any medication, consultation with a healthcare provider is essential to tailor the treatment to individual needs and conditions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-mr-30-133422", "price": 83.0, "discountamount": 24.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "life", "body", "drops", "EMAIL", "Order", "upset", "tablet", "nausea", "stomach", "quality", "SR) form", "patients", "Benefits", "pancreas", "adherence", "integrity", "breakfast", "practical", "lower risk", "SR version", "medication", "conditions", "Conclusion", "individuals", "information", "sterisonline", "Introduction", "30 mg dosage", "consultation", "sterispharma", "hypoglycemia", "CALL/WHATSAPP", "Gliclazide SR", "HbA1c) levels", "SR formulation", "GLICLAGLAZE MR", "first main meal", "Type 2 diabetes", "mild enhancement", "individual needs", "excellent choice", "insulin secretion", "effective solution", "Regular monitoring", "blood sugar spikes", "healthcare provider", "diabetes management", "gentle modification", "other sulfonylureas", "common side effects", "glycated hemoglobin", "severe fluctuations", "natural insulin use", "Possible side effects", "standard formulations", "Administration Dosage", "sulfonylurea component", "sustained drug release", "blood glucose response", "cardiovascular disease", "diabetes treatment plan", "stable glycemic control", "gastrointestinal issues", "overall vascular health", "sulfonylurea class drug", "steady, controlled release", "optimal blood sugar levels", "previous treatment history", "sustained release mechanism", "dosage-related complications", "sustained release formulation", "predictable pharmacokinetic profile" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1291, "imageuri": "https://productimages.withfloats.com/actual/665ef7d253245b8b6b459895.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef7d253245b8b6b459895.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:17:35.736Z", "updatedon": "2024-06-04T11:17:35.736Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-mr-30-/1291", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MR 30 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665dbb06dce9381dfcc553b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 10/100 SR ", "description": "DAPA VILDA 10/100 SR \nDapagliflozin (10mg), Vildagliptin SR (100mg)\nIntroduction to DAPA VILDA 10/100 SR\nDAPA VILDA 10/100 SR is a combination medication that includes Dapagliflozin 10mg and Vildagliptin 100mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Dapagliflozin and Vildagliptin work together to improve blood sugar control through complementary mechanisms, making this combination an effective treatment option for patients needing comprehensive glycemic management.\n\nWhat are Dapagliflozin and Vildagliptin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Vildagliptin\nVildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of DAPA VILDA 10/100 SR\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Vildagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nConvenience and Compliance\nOnce-Daily Dosing: The sustained-release formulation of Vildagliptin allows for once-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use DAPA VILDA 10/100 SR\nDosage and Administration\nRecommended Dosage: The typical dosage of DAPA VILDA 10/100 SR is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food, preferably at the same time each day to maintain consistent blood levels of the medication. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take DAPA VILDA 10/100 SR regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "risk", "urine", "EMAIL", "Order", "meals", "water", "action", "kidneys", "one pill", "calories", "readings", "Overview", "same time", "full glass", "Guidelines", "one tablet", "Optimal Use", "Adjustments", "information", "weight loss", "Convenience", "Introduction", "Daily Dosing", "best results", "sterisonline", "sterispharma", "Postprandial", "CALL/WHATSAPP", "heart failure", "treatment plan", "Administration", "typical dosage", "dual mechanism", "Consistent Use", "sodium-glucose", "glucagon levels", "two medications", "insulin release", "Vildagliptin SR", "Weight Reduction", "prolonged effect", "SGLT2 inhibitors", "diabetic patients", "treatment regimen", "Weight Management", "glucose excretion", "multiple pathways", "Dapagliflozin 10mg", "prescribed therapy", "patient compliance", "blood sugar levels", "glucose regulation", "Recommended Dosage", "individual response", "blood sugar control", "healthcare provider", "Reduced Pill Burden", "meal) glucose levels", "blood glucose levels", "DAPA VILDA 10/100 SR", "combination medication", "Fasting Glucose Control", "consistent blood levels", "Cardiovascular Benefits", "transporter-2) inhibitor", "complementary mechanisms", "type 2 diabetes mellitus", "natural incretin hormones", "Cardiovascular Protection", "effective treatment option", "other cardiovascular events", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive glycemic management", "dipeptidyl peptidase-4) inhibitor", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1253, "imageuri": "https://productimages.withfloats.com/actual/665dbb093b5550f17788eb4e.png", "tileimageuri": "https://productimages.withfloats.com/tile/665dbb093b5550f17788eb4e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:45:58.06Z", "updatedon": "2024-06-03T12:45:58.06Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-10-100-sr-/1253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 10/100 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }